INR 28.91
(-1.23%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.5 Billion INR | -7.93% |
2022 | 1.63 Billion INR | -17.75% |
2021 | 1.99 Billion INR | -4.16% |
2020 | 2.07 Billion INR | -10.4% |
2019 | 2.31 Billion INR | -10.25% |
2018 | 2.58 Billion INR | -9.86% |
2017 | 2.86 Billion INR | 26.25% |
2016 | 2.27 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 FY | 1.5 Billion INR | -7.93% |
2023 Q2 | 1.65 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 1.5 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q2 | 1.8 Billion INR | 0.0% |
2022 Q4 | 1.63 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 1.63 Billion INR | -17.75% |
2022 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 1.99 Billion INR | -4.16% |
2021 Q4 | 1.99 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 1.98 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q4 | 2.07 Billion INR | 0.0% |
2020 FY | 2.07 Billion INR | -10.4% |
2020 Q2 | 2.01 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 2.31 Billion INR | -10.25% |
2019 Q4 | 2.31 Billion INR | 0.0% |
2019 Q2 | 2.36 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q1 | - INR | -100.0% |
2018 FY | 2.58 Billion INR | -9.86% |
2018 Q4 | 2.58 Billion INR | 0.0% |
2018 Q2 | 2.63 Billion INR | 0.0% |
2017 Q2 | 2.81 Billion INR | 0.0% |
2017 Q1 | - INR | 0.0% |
2017 FY | 2.86 Billion INR | 26.25% |
2017 Q4 | 2.86 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2016 FY | 2.27 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Sigachi Industries Limited | 6.94 Billion INR | 78.266% |
Ind-Swift Limited | 6.54 Billion INR | 76.948% |
Bajaj HealthCare Limited | 7.65 Billion INR | 80.282% |
Sakar Healthcare Limited | 3.88 Billion INR | 61.182% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.665% |
Innova Captab Limited | 13.2 Billion INR | 88.578% |
Divi's Laboratories Limited | 154.7 Billion INR | 99.025% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 86.005% |
Morepen Laboratories Limited | 12.93 Billion INR | 88.334% |
Mankind Pharma Limited | 119.63 Billion INR | 98.739% |
Sequent Scientific Limited | 15.4 Billion INR | 90.206% |
Wanbury Limited | 3.43 Billion INR | 56.078% |
Laurus Labs Limited | 83.87 Billion INR | 98.201% |
Nectar Lifesciences Limited | 21.91 Billion INR | 93.114% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 94.707% |
Alembic Limited | 23.28 Billion INR | 93.522% |
Hikal Limited | 24.87 Billion INR | 93.934% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 97.659% |
Neuland Laboratories Limited | 18.32 Billion INR | 91.767% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 96.223% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 98.949% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 93.278% |
Themis Medicare Limited | 5.66 Billion INR | 73.364% |
RPG Life Sciences Limited | 5.12 Billion INR | 70.583% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.485% |
Lupin Limited | 239.97 Billion INR | 99.371% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 58.877% |
Wockhardt Limited | 76.49 Billion INR | 98.028% |
Vaishali Pharma Limited | 799.55 Million INR | -88.69% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 94.157% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 30.5% |
Jubilant Pharmova Limited | 115.48 Billion INR | 98.694% |
FDC Limited | 24.68 Billion INR | 93.887% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.611% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 37.154% |
Eris Lifesciences Limited | 70.48 Billion INR | 97.86% |
Venus Remedies Limited | 6.26 Billion INR | 75.931% |
ZIM Laboratories Limited | 4.46 Billion INR | 66.235% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 87.571% |
Par Drugs and Chemicals Limited | 1.01 Billion INR | -48.477% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 94.407% |
Shilpa Medicare Limited | 30.93 Billion INR | 95.123% |
Albert David Limited | 4.97 Billion INR | 69.705% |
Ajanta Pharma Limited | 46.38 Billion INR | 96.747% |
Hester Biosciences Limited | 6.62 Billion INR | 77.222% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 93.307% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 93.571% |
Gufic Biosciences Limited | 10.92 Billion INR | 86.191% |
Windlas Biotech Limited | 6.26 Billion INR | 75.907% |
Procter & Gamble Health Limited | 7.94 Billion INR | 81.008% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | 50.534% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 54.752% |
Granules India Limited | 55.2 Billion INR | 97.267% |
Aarti Drugs Limited | 24.32 Billion INR | 93.797% |
Bal Pharma Limited | 3.2 Billion INR | 52.911% |
Alkem Laboratories Limited | 155.74 Billion INR | 99.031% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.823% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | 78.456% |
Medicamen Biotech Limited | 2.94 Billion INR | 48.775% |
Unichem Laboratories Limited | 31.69 Billion INR | 95.24% |
Bafna Pharmaceuticals Limited | 1.47 Billion INR | -2.158% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -220.433% |
Valiant Laboratories Limited | 3.42 Billion INR | 55.975% |
Orchid Pharma Limited | 15.53 Billion INR | 90.291% |
Medico Remedies Limited | 961.95 Million INR | -56.836% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 87.051% |
Ipca Laboratories Limited | 111.01 Billion INR | 98.641% |
Brooks Laboratories Limited | 904.45 Million INR | -66.806% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 62.718% |
Piramal Enterprises Limited | 826.05 Billion INR | 99.817% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 98.998% |
NATCO Pharma Limited | 69.06 Billion INR | 97.815% |
Suven Life Sciences Limited | 2.84 Billion INR | 47.046% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 15.325% |
Strides Pharma Science Limited | 58.39 Billion INR | 97.417% |
Indoco Remedies Limited | 21.44 Billion INR | 92.966% |
Alpa Laboratories Limited | 1.82 Billion INR | 17.387% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 70.707% |